保留肝实质肝切除与右半肝切除治疗孤立小 colorectal 肝转移的结局:LiverMetSurvey 研究
该多中心队列研究纳入 2000–2015 年 LiverMetSurvey 登记中 1720 例右肝孤立小(<30 mm)结直肠癌肝转移患者,比较保留肝实质肝切除(1478 例)与右半肝切除(242 例)的短期和长期结局。保留肝实质肝切除组主要并发症和 90 天死亡率更低,肝复发率相似,5 年无复发生存和总生存相似;但在肝-only 复发患者中,保留肝实质肝切除组再次肝切除率更高且 5 年总生存显著更高。结论认为保留肝实质肝切除应作为右肝孤立小 colorectal 肝转移在技术可行时的标准术式。
要点
- 右肝孤立小 colorectal 肝转移,保留肝实质肝切除较右半肝切除主要并发症和 90 天死亡率更低
- 两组肝复发率、5 年无复发生存和总生存相似
- 肝-only 复发时保留肝实质肝切除组再次肝切除率更高、5 年总生存更高
核心结论
- 保留肝实质肝切除应作为右肝孤立小 colorectal 肝转移在技术可行时的标准术式。
研究设计与样本
- 多中心队列研究,数据来自 LiverMetSurvey 登记,2000–2015 年共 21072 例 colorectal 肝转移手术患者。
- 纳入病理确诊的右肝孤立肿瘤且大小小于 30 mm 的患者,共 1720 例。
- 比较保留肝实质肝切除(1478 例,86%)与右半肝切除(242 例,14%)的短期和长期结局。
主要发现
- 保留肝实质肝切除组主要并发症发生率 3%,右半肝切除组 10%(P < .001)。
- 保留肝实质肝切除组 90 天死亡率 1%,右半肝切除组 3%(P = .008)。
- 两组肝复发率分别为 20% 与 22%(P = .39),5 年无复发生存和总生存相似。
- 肝-only 复发患者中,保留肝实质肝切除组再次肝切除率 67%,右半肝切除组 31%(P < .001)。
- 肝-only 复发患者中,保留肝实质肝切除组 5 年总生存率 55%,右半肝切除组 23%(P < .001)。
临床怎么用
- 对右肝孤立小 colorectal 肝转移,技术可行时优先选择保留肝实质肝切除而非右半肝切除。
- 保留肝实质肝切除可能降低主要并发症和 90 天死亡风险,并为肝-only 复发保留再次肝切除机会。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Occasionally, right hepatectomy, rather than parenchyma-preserving hepatectomy, has been performed for solitary small colorectal liver metastasis. The relative oncologic benefits of parenchyma-preserving hepatectomy and right hepatectomy are unclear. This study compared the outcomes of patients with solitary small colorectal liver metastasis in the right liver who underwent parenchyma-preserving hepatectomy and those who underwent right hepatectomy. METHODS: The study population consisted of a multicentric cohort of 21,072 patients operated for colorectal liver metastasis between 2000 and 2015 whose data were collected in the LiverMetSurvey registry. Patients with a pathologically confirmed solitary tumor of less than 30 mm in size in the right liver were included. The short- and long-term outcomes of patients who underwent parenchyma-preserving hepatectomy were compared to those of patients who underwent right hepatectomy. RESULTS: Of the 1,720 patients who were eligible for the study, 1,478 (86%) underwent parenchyma-preserving hepatectomy and 242 (14%) underwent right hepatectomy. The parenchyma-preserving hepatectomy group was associated with lower rates of major complications (3% vs 10%; P < .001) and 90-day mortality (1% vs 3%; P = .008). Liver recurrence occurred similarly in both groups (20% vs 22%; P = .39). The 5-year recurrence-free survival and overall survival rates were similar in both groups. However, in patients with liver-only recurrence, repeat hepatectomy was more frequently performed in the parenchyma-preserving hepatectomy group than in the right hepatectomy group (67% vs 31%; P < .001), and the overall 5-year survival rate was significantly higher in the parenchyma-preserving hepatectomy group than in the right hepatectomy group (55% vs 23%; P < .001). CONCLUSION: Parenchyma-preserving hepatectomy should be considered the standard procedure for solitary small colorectal liver metastasis in the right liver when technically feasible.
引用
- Hosokawa I, Allard MA, Mirza DF, et al. Outcomes of parenchyma-preserving hepatectomy and right hepatectomy for solitary small colorectal liver metastasis: A LiverMetSurvey study. Surgery. 2017. PMID: 28434557. doi:10.1016/j.surg.2017.02.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。